英文名稱 | Ritlecitinib Tosylate |
---|---|
中文名稱 | 利特昔替尼對(duì)甲苯磺酸鹽 |
CAS號(hào) | 2192215-81-7 |
分子式 | C22H27N5O4S |
分子量 | 457.55 |
外觀 | White to off-white powder |
儲(chǔ)存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
規(guī)格 | 庫(kù)存 | 目錄價(jià) | 會(huì)員專享價(jià) | 數(shù)量 | |
---|---|---|---|---|---|
暫無(wú)牌價(jià)信息,您可以發(fā)送詢價(jià),我們會(huì)盡快給你回復(fù)。 |
英文名稱 | Ritlecitinib Tosylate |
---|---|
中文名稱 | 利特昔替尼對(duì)甲苯磺酸鹽 |
CAS號(hào) | 2192215-81-7 |
分子式 | C22H27N5O4S |
分子量 | 457.55 |
外觀 | White to off-white powder |
儲(chǔ)存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Ritlecitinib, also known as PF-06651600, is a potent and selective JAK3 inhibitor. PF-06651600 is a potent and low clearance compound with demonstrated in vivo efficacy. The favorable efficacy and safety profile of this JAK3-specific inhibitor PF-06651600 led to its evaluation in several human clinical studies. JAK3 was among the first of the JAKs targeted for therapeutic intervention due to the strong validation provided by human SCID patients displaying JAK3 deficiencies.